recombinant alk1 fc Search Results


human recombinant chimeric alk 2 fc  (R&D Systems)
94
R&D Systems human recombinant chimeric alk 2 fc
Human Recombinant Chimeric Alk 2 Fc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human recombinant chimeric alk 2 fc/product/R&D Systems
Average 94 stars, based on 1 article reviews
human recombinant chimeric alk 2 fc - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
recombinant mouse alk1fc  (R&D Systems)
91
R&D Systems recombinant mouse alk1fc
FSS stimulation activates multiple distinct TGFβ family type I receptors in OCY454 cells. A, qRT‐PCR analysis of TGFβ target gene Serpine1 after 60‐minute treatment with vehicle or SB‐431542 followed by 120‐minute treatment with TGFβ or FSS stimulation as indicated (n = 4 biological replicates). All values normalized to control cells. * P < .05 compared to unstimulated cells and # P < .05 compared to SB‐treated controls; † P < .05 compared to corresponding treatment group without SB‐431542, ‡ P < .05 compared to FSS‐stimulated cells. B, C, Representative western analysis of Smad phosphorylation in control cells and cells pretreated (60 minutes) with vehicle or an inhibitor of a subset of TGFβ type I receptors (SB‐431542, ALK4/5/7 inhibitor; LDN‐193189, ALK1/2/3/6 inhibitor; LDN‐214117, ALK1/2 inhibitor, as shown in B), followed by treatment (30 minutes) with TGFβ or FSS (C) (n = 3 biological replicates). D, Representative western analysis of cells pretreated (60 minutes) with <t>ALK1Fc</t> followed by treatment (30 minutes) with TGFβ, BMP4, or FSS (n = 2 biological replicates, non‐flow conditions were collected from cells grown in well plates)
Recombinant Mouse Alk1fc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse alk1fc/product/R&D Systems
Average 91 stars, based on 1 article reviews
recombinant mouse alk1fc - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier
recombinant mouse alk1 extracellular domain  (R&D Systems)
92
R&D Systems recombinant mouse alk1 extracellular domain
FSS stimulation activates multiple distinct TGFβ family type I receptors in OCY454 cells. A, qRT‐PCR analysis of TGFβ target gene Serpine1 after 60‐minute treatment with vehicle or SB‐431542 followed by 120‐minute treatment with TGFβ or FSS stimulation as indicated (n = 4 biological replicates). All values normalized to control cells. * P < .05 compared to unstimulated cells and # P < .05 compared to SB‐treated controls; † P < .05 compared to corresponding treatment group without SB‐431542, ‡ P < .05 compared to FSS‐stimulated cells. B, C, Representative western analysis of Smad phosphorylation in control cells and cells pretreated (60 minutes) with vehicle or an inhibitor of a subset of TGFβ type I receptors (SB‐431542, ALK4/5/7 inhibitor; LDN‐193189, ALK1/2/3/6 inhibitor; LDN‐214117, ALK1/2 inhibitor, as shown in B), followed by treatment (30 minutes) with TGFβ or FSS (C) (n = 3 biological replicates). D, Representative western analysis of cells pretreated (60 minutes) with <t>ALK1Fc</t> followed by treatment (30 minutes) with TGFβ, BMP4, or FSS (n = 2 biological replicates, non‐flow conditions were collected from cells grown in well plates)
Recombinant Mouse Alk1 Extracellular Domain, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse alk1 extracellular domain/product/R&D Systems
Average 92 stars, based on 1 article reviews
recombinant mouse alk1 extracellular domain - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier
370 al 100  (R&D Systems)
93
R&D Systems 370 al 100

370 Al 100, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/370 al 100/product/R&D Systems
Average 93 stars, based on 1 article reviews
370 al 100 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

Image Search Results


FSS stimulation activates multiple distinct TGFβ family type I receptors in OCY454 cells. A, qRT‐PCR analysis of TGFβ target gene Serpine1 after 60‐minute treatment with vehicle or SB‐431542 followed by 120‐minute treatment with TGFβ or FSS stimulation as indicated (n = 4 biological replicates). All values normalized to control cells. * P < .05 compared to unstimulated cells and # P < .05 compared to SB‐treated controls; † P < .05 compared to corresponding treatment group without SB‐431542, ‡ P < .05 compared to FSS‐stimulated cells. B, C, Representative western analysis of Smad phosphorylation in control cells and cells pretreated (60 minutes) with vehicle or an inhibitor of a subset of TGFβ type I receptors (SB‐431542, ALK4/5/7 inhibitor; LDN‐193189, ALK1/2/3/6 inhibitor; LDN‐214117, ALK1/2 inhibitor, as shown in B), followed by treatment (30 minutes) with TGFβ or FSS (C) (n = 3 biological replicates). D, Representative western analysis of cells pretreated (60 minutes) with ALK1Fc followed by treatment (30 minutes) with TGFβ, BMP4, or FSS (n = 2 biological replicates, non‐flow conditions were collected from cells grown in well plates)

Journal: The FASEB Journal

Article Title: Fluid shear stress generates a unique signaling response by activating multiple TGFβ family type I receptors in osteocytes

doi: 10.1096/fj.202001998R

Figure Lengend Snippet: FSS stimulation activates multiple distinct TGFβ family type I receptors in OCY454 cells. A, qRT‐PCR analysis of TGFβ target gene Serpine1 after 60‐minute treatment with vehicle or SB‐431542 followed by 120‐minute treatment with TGFβ or FSS stimulation as indicated (n = 4 biological replicates). All values normalized to control cells. * P < .05 compared to unstimulated cells and # P < .05 compared to SB‐treated controls; † P < .05 compared to corresponding treatment group without SB‐431542, ‡ P < .05 compared to FSS‐stimulated cells. B, C, Representative western analysis of Smad phosphorylation in control cells and cells pretreated (60 minutes) with vehicle or an inhibitor of a subset of TGFβ type I receptors (SB‐431542, ALK4/5/7 inhibitor; LDN‐193189, ALK1/2/3/6 inhibitor; LDN‐214117, ALK1/2 inhibitor, as shown in B), followed by treatment (30 minutes) with TGFβ or FSS (C) (n = 3 biological replicates). D, Representative western analysis of cells pretreated (60 minutes) with ALK1Fc followed by treatment (30 minutes) with TGFβ, BMP4, or FSS (n = 2 biological replicates, non‐flow conditions were collected from cells grown in well plates)

Article Snippet: Except where noted in the figures, cells were treated as indicated with TGFβ1 (5 ng/mL), BMP4 (50 ng/mL) (both from Peprotech); 1d11 (1.25 µg/mL, Clone 1d11.16.8, BioXCell); Noggin (100 ng/mL, SRP3227, Sigma Aldrich); SB‐431542 (10 µM), LDN‐193189 (1 µM), LDN‐214117 (1 µM), SC‐79 (10 µM) (all from Selleckchem); recombinant mouse ALK1Fc (100 ng/mL, R&D Systems); and LY294002 (50 µM, Calbiochem).

Techniques: Quantitative RT-PCR, Western Blot

Journal: eLife

Article Title: YAP and TAZ regulate adherens junction dynamics and endothelial cell distribution during vascular development

doi: 10.7554/eLife.31037

Figure Lengend Snippet:

Article Snippet: chemical compound, drug , Recombinant hAlk1fc , R and D Systems, 370-AL-100 , , .

Techniques: Clone Assay, Transfection, Construct, Plasmid Preparation, Luciferase, Sequencing, Permeability, Scratch Wound Assay Assay, Imaging, Staining, Recombinant, Software, Translocation Assay